PLPL (Plandai Biotechnology) Current Accrued Expense: $0.06 Mil (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Plandai Biotechnology Current Accrued Expense?

Plandai Biotechnology PLPL -90.00% Current Accrued Expense is $0.06 Mil as of Jun. 2023.

Plandai Biotechnology's Current Accrued Expense for the quarter that ended in Jun. 2023 was $0.06 Mil.

Plandai Biotechnology's quarterly Current Accrued Expense declined from Jun. 2016 ($0.74 Mil) to Jun. 2022 ($0.11 Mil) and declined from Jun. 2022 ($0.11 Mil) to Jun. 2023 ($0.06 Mil).

Plandai Biotechnology's annual Current Accrued Expense declined from Jun. 2016 ($0.74 Mil) to Jun. 2022 ($0.11 Mil) and declined from Jun. 2022 ($0.11 Mil) to Jun. 2023 ($0.06 Mil).

Plandai Biotechnology Current Accrued Expense Related Terms

Plandai Biotechnology Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Plandai Biotechnology's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Plandai Biotechnology Current Accrued Expense Chart

Plandai Biotechnology Annual Data
Trend Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.04 0.29 0.74 0.11 0.06

Plandai Biotechnology Semi-Annual Data
Mar03 Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun22 Jun23
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.29 0.74 0.11 0.06

Plandai Biotechnology Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.06 Mil mean?
Plandai Biotechnology (PLPL) has a Current Accrued Expense of $0.06 Mil as of Jun. 2023. Current Accrued Expense records the total amount of accrued expenses. View historical data on Plandai Biotechnology and its competitors.
Is Plandai Biotechnology's Current Accrued Expense too high?
Plandai Biotechnology's current Current Accrued Expense is $0.06 Mil.
How does Plandai Biotechnology's Current Accrued Expense compare to CRGH and TCRI?
Plandai Biotechnology's Current Accrued Expense of $0.06 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Business Services company?
A good Current Accrued Expense depends on the Business Services industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Plandai Biotechnology and its competitors. Plandai Biotechnology's current Current Accrued Expense is $0.06 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plandai Biotechnology stock overvalued right now?
Plandai Biotechnology (PLPL) has a current Current Accrued Expense of $0.06 Mil. The current Current Accrued Expense is $0.06 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Plandai Biotechnology (PLPL), the current Current Accrued Expense is $0.06 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Plandai Biotechnology Business Description

Address Xinyi Road, Sector 5, No. 7, 57th Floor - 1, Xinyi District, Taipei, TWN, 330
Plandai Biotechnology Inc is engaged in catering and catering management operations in Taiwan.